Home > Products > CD32B & malaria antigen > Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv)

Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv)  (CAT#: BSTF-H289)

Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv) is designed to be expressed as one chain, then assembled to a homodimer of bivalent scFv fragments and the Fc region of IgG. The anti-CD32B scFv is fused to the N-terminus of Fc via a hinge region while another anti-malaria antigen scFv is linked to the C-terminus of Fc. This scFv-Fc-scFv format has 2+2 antigen-binding valency by employing different scFv fragments. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.
Datasheet INQUIRY

Specifications

Targets
CD32B & malaria antigen
Type
scFv-based Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Malaria

Targets

Target 1
CD32B
Gene ID
UniProt ID
Alternative Names
FCGR2B; Fc fragment of IgG, low affinity IIb, receptor (CD32); FcγRIIB; CD32; FCG2; CD32B; FCGR2; IGFR2; low affinity immunoglobulin gamma Fc region receptor II-b; CDw32; fcRII-b; Fc gamma RIIb; fc-gamma-RIIb; fc-gamma RII-b; igG Fc receptor II-b; Fc fragment of IgG, low affinity II, receptor for (CD32); Fc fragment of IgG, low affinity IIb, receptor for (CD32)
Target 2
malaria antigen
Alternative Names
malaria antigen; parasitic protozoans
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD32B & malaria antigen"
See other bsAb targets related to "CD32B"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD32B x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv) (BSTF-H289). Click the button below to contact us or submit your feedback about this product.